IL-13 binding protein
US8680245B2 · kind B2 · utility
2Cited by
3References
79Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 26, 2010 |
| Grant date | Mar 25, 2014 |
| Priority date | — |
| Expiry date | May 26, 2030 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to antigen binding proteins to human IL-13, including anti-IL-13 antibodies and anti-IL-3/anti-IL-4 mAbdAbs, pharmaceutical formulations containing them and to the use of such antigen binding proteins in the treatment and/or prophylaxis of inflammatory diseases such as asthma or IPF.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.